Window Trial of Fluorescently Labeled Nivolumab-IRDye800 (Nivo800) in High Grade Glioma (HGG)

Clinical trial NCT07210632 · RECRUITING

Trial details

NCT number: NCT07210632
Sponsor: Eben Rosenthal
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Brain Cancer HGG Glioma High Grade Glioma High Grade Gliomas High Grade Glioma (III or IV)High Grade Glioma (HGG) of the Brain With BRAF Aberration

Start date: 2026-03-27
Primary completion: 2030-03-30
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.